Company family · HQ IL
Teva: medicine shortages
TEVA · NYSE / TASE
As of 2 Nov 2026, 903 Teva products have a reported shortage across 14 countries, covering 289 medicines.
Products short903rank #2 of 464
Medicines289active ingredients
Countries14/16
New in 90 days300+71 vs market pace
Typical duration6 monthsmedian so far
Manufacturing72%demand-driven 9%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
When its current shortages began
Long-run trend in Canada
Canada dashboardCanada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Risperidone | 26 | 17 May 2017 | Manufacturing problem | 13/16 | |
| Quetiapine | 23 | 24 Apr 2025 | Increased demand | 12/16 | |
| Simvastatin | 18 | 8 Apr 2026 | Manufacturing problem | 9/16 | |
| Aripiprazole | 17 | 15 Feb 2024 | Commercial decision or withdrawal | 9/16 | |
| Galantamine | 15 | 1 Mar 2025 | Increased demand | 7/16 | |
| Olanzapine | 15 | 7 Jun 2025 | Manufacturing problem | 13/16 | |
| Carboplatin | 12 | 21 Oct 2020 | Not stated | 10/16 | |
| Pregabalin | 12 | 17 May 2017 | Manufacturing problem | 11/16 | |
| Tolterodine | 11 | 4 Oct 2023 | Manufacturing problem | 8/16 | |
| Methylphenidate | 10 | 30 Jan 2018 | Not stated | 9/16 | |
| Gabapentin | 9 | 18 Aug 2017 | Commercial decision or withdrawal | 9/16 | |
| Allopurinol | 8 | 19 Feb 2026 | Not stated | 9/16 | |
| Bisoprolol | 8 | 30 Jun 2026 | Manufacturing problem | 6/16 | |
| Celecoxib | 8 | 17 Feb 2021 | Not stated | 8/16 | |
| Clonazepam | 8 | 11 Aug 2017 | Not stated | 4/16 | |
| Diltiazem | 8 | 1 Mar 2018 | Manufacturing problem | 7/16 | |
| Donepezil | 8 | 30 Jan 2025 | Manufacturing problem | 8/16 | |
| Ondansetron | 8 | 29 Feb 2016 | Manufacturing problem | 9/16 | |
| Ramipril | 8 | 2 Oct 2026 | Manufacturing problem | 10/16 | |
| Sumatriptan | 8 | 15 Jul 2026 | Manufacturing problem | 13/16 | |
| Bupropion | 7 | 1 Feb 2024 | Manufacturing problem | 7/16 | |
| Diazepam | 7 | 1 Aug 2024 | Manufacturing problem | 7/16 | |
| Lisdexamfetamine | 7 | 14 Jul 2023 | Not stated | 5/16 | |
| Meloxicam | 7 | 8 Jan 2020 | Manufacturing problem | 3/16 | |
| Metformin | 7 | 22 Jan 2026 | Manufacturing problem | 8/16 | |
| Metoprolol | 7 | 31 Aug 2026 | Not stated | 9/16 | |
| Buprenorphine | 6 | 13 Mar 2024 | Increased demand | 7/16 | |
| Diclofenac | 6 | 13 Aug 2026 | Not stated | 1/16 | |
| Docetaxel | 6 | 29 Feb 2016 | Not stated | 8/16 | |
| Escitalopram | 6 | 17 Jun 2026 | Manufacturing problem | 10/16 | |
| Fentanyl | 6 | 16 Oct 2025 | Manufacturing problem | 9/16 | |
| Paliperidone | 6 | 23 Jul 2024 | Increased demand | 11/16 | |
| Pirfenidone | 6 | 8 Apr 2026 | Manufacturing problem | 6/16 | |
| Pravastatin | 6 | 17 Mar 2017 | Manufacturing problem | 6/16 | |
| Sertraline | 6 | 17 Mar 2017 | Manufacturing problem | 11/16 | |
| Sildenafil | 6 | 14 Sep 2026 | Manufacturing problem | 10/16 | |
| Simvastatin and Ezetimibe | 6 | 19 Mar 2025 | Manufacturing problem | 8/16 | |
| Trabectedin | 6 | 1 Jan 2026 | Not stated | 6/16 | |
| Amlodipine | 5 | 13 Jul 2026 | Manufacturing problem | 8/16 | |
| Dabigatran Etexilate | 5 | 13 Jul 2026 | Commercial decision or withdrawal | 10/16 | |
| Esomeprazole | 5 | 23 Apr 2025 | Manufacturing problem | 9/16 | |
| Lercanidipine | 5 | 24 Nov 2025 | Distribution or logistics | 4/16 | |
| Perindopril and Diuretics | 5 | 28 Aug 2026 | Increased demand | 6/16 | |
| Pomalidomide | 5 | 10 Apr 2026 | Manufacturing problem | 6/16 | |
| Repaglinide | 5 | 1 Nov 2021 | Manufacturing problem | 5/16 | |
| Rosuvastatin | 5 | 15 Sep 2026 | Manufacturing problem | 12/16 | |
| Telmisartan and Diuretics | 5 | 16 Jul 2025 | Manufacturing problem | 4/16 | |
| Varenicline | 5 | 21 Oct 2020 | Manufacturing problem | 4/16 | |
| Alendronic Acid and Colecalciferol | 4 | 30 Oct 2017 | Active ingredient shortage | 5/16 | |
| Apremilast | 4 | 7 May 2026 | Not stated | 5/16 | |
| Atorvastatin | 4 | 29 Jun 2016 | Manufacturing problem | 11/16 | |
| Bendamustine | 4 | 3 Sep 2026 | Not stated | 7/16 | |
| Candesartan | 4 | 10 Dec 2025 | Not stated | 10/16 | |
| Cinacalcet | 4 | 9 Jun 2023 | Regulatory or licensing | 11/16 | |
| Clarithromycin | 4 | 27 Aug 2024 | Manufacturing problem | 5/16 | |
| Codeine, Combinations excl. Psycholeptics | 4 | 1 Mar 2013 | Manufacturing problem | 1/16 | |
| Colistin | 4 | 1 Jun 2026 | Manufacturing problem | 6/16 | |
| Doxorubicin | 4 | 6 Jun 2024 | Manufacturing problem | 8/16 | |
| Everolimus | 4 | 2 Mar 2026 | Not stated | 3/16 | |
| Famciclovir | 4 | 1 Sep 2018 | Manufacturing problem | 2/16 | |
| Guanfacine | 4 | 13 Nov 2025 | Not stated | 3/16 | |
| Levodopa and Decarboxylase Inhibitor | 4 | 28 Nov 2019 | Manufacturing problem | 4/16 | |
| Lisinopril | 4 | 3 Aug 2026 | Manufacturing problem | 5/16 | |
| Memantine | 4 | 13 Jul 2026 | Manufacturing problem | 8/16 | |
| Metformin and Sitagliptin | 4 | 18 Mar 2025 | Manufacturing problem | 3/16 | |
| Methotrexate | 4 | 13 Mar 2023 | Other | 6/16 | |
| Moxifloxacin | 4 | 4 Jun 2025 | Manufacturing problem | 8/16 | |
| Paracetamol | 4 | 3 Jun 2026 | Manufacturing problem | 10/16 | |
| Perindopril | 4 | 17 Sep 2026 | Manufacturing problem | 5/16 | |
| Perindopril and Amlodipine | 4 | 18 Sep 2026 | Manufacturing problem | 5/16 | |
| Perindopril, Amlodipine and Indapamide | 4 | 10 Aug 2026 | Manufacturing problem | 1/16 | |
| Pioglitazone | 4 | 27 Aug 2026 | Manufacturing problem | 7/16 | |
| Pramipexole | 4 | 24 Mar 2026 | Increased demand | 6/16 | |
| Rabeprazole | 4 | 17 Feb 2023 | Distribution or logistics | 5/16 | |
| Sitagliptin | 4 | 5 Mar 2025 | Manufacturing problem | 8/16 | |
| Sunitinib | 4 | 9 Mar 2026 | Manufacturing problem | 5/16 | |
| Tacrolimus | 4 | 30 Jun 2026 | Manufacturing problem | 6/16 | |
| Tiagabine | 4 | 15 Apr 2026 | Not stated | 1/16 | |
| Amcinonide | 3 | 17 May 2017 | Manufacturing problem | 1/16 | |
| Amoxicillin and Beta-Lactamase Inhibitor | 3 | 15 Mar 2024 | Increased demand | 7/16 | |
| Anagrelide | 3 | 19 Nov 2025 | Not stated | 3/16 | |
| Anastrozole | 3 | 20 Sep 2026 | Manufacturing problem | 5/16 | |
| Atenolol | 3 | 22 Jan 2020 | Manufacturing problem | 6/16 | |
| Azithromycin | 3 | 5 Jul 2026 | Not stated | 9/16 | |
| Benzylpenicillin | 3 | 25 Jan 2016 | Manufacturing problem | 4/16 | |
| Bicalutamide | 3 | 11 May 2026 | Manufacturing problem | 6/16 | |
| Budesonide | 3 | 31 Dec 2025 | Not stated | 4/16 | |
| Buprenorphine | 3 | 25 May 2026 | Not stated | 4/16 | |
| Carvedilol | 3 | 16 Mar 2026 | Distribution or logistics | 8/16 | |
| Ciprofloxacin | 3 | 12 Nov 2024 | Manufacturing problem | 9/16 | |
| Epirubicin | 3 | 11 Mar 2026 | Not stated | 7/16 | |
| Erythropoietin | 3 | 5 Oct 2026 | Manufacturing problem | 6/16 | |
| Etoposide | 3 | 5 Jan 2026 | Manufacturing problem | 7/16 | |
| Felodipine | 3 | 18 Aug 2026 | Manufacturing problem | 5/16 | |
| Fingolimod | 3 | 3 Mar 2026 | Not stated | 9/16 | |
| Fluocinonide | 3 | 2 Oct 2026 | Not stated | 1/16 | |
| Hydrocortisone | 3 | 29 Feb 2016 | Manufacturing problem | 4/16 | |
| Hydromorphone | 3 | 1 Nov 2017 | Not stated | 5/16 | |
| Imatinib | 3 | 10 Aug 2026 | Not stated | 6/16 | |
| Isotretinoin | 3 | 9 Sep 2026 | Increased demand | 4/16 | |
| Levetiracetam | 3 | 16 Feb 2026 | Manufacturing problem | 9/16 | |
| Lipegfilgrastim | 3 | 12 Feb 2026 | Manufacturing problem | 4/16 | |
| Mirtazapine | 3 | 7 Jul 2026 | Distribution or logistics | 10/16 | |
| Montelukast | 3 | 18 Sep 2026 | Manufacturing problem | 13/16 | |
| Octreotide | 3 | 2 Jan 2025 | Not stated | 6/16 | |
| Omeprazole | 3 | 7 Nov 2024 | Manufacturing problem | 8/16 | |
| Pantoprazole | 3 | 8 Nov 2023 | Manufacturing problem | 9/16 | |
| Potassium Chloride | 3 | 21 Nov 2025 | Not stated | 5/16 | |
| Ranolazine | 3 | 29 Jun 2026 | Distribution or logistics | 4/16 | |
| Rivaroxaban | 3 | 10 Jun 2025 | Manufacturing problem | 13/16 | |
| Sulfamethoxazole and Trimethoprim | 3 | 1 Feb 2017 | Manufacturing problem | 5/16 | |
| Tamoxifen | 3 | 7 Feb 2024 | Manufacturing problem | 4/16 | |
| Temozolomide | 3 | 1 Apr 2026 | Manufacturing problem | 6/16 | |
| Tenofovir Disoproxil and Emtricitabine | 3 | 20 Jan 2025 | Manufacturing problem | 5/16 | |
| Topiramate | 3 | 1 Apr 2026 | Distribution or logistics | 8/16 | |
| Valproic Acid | 3 | 21 Sep 2026 | Manufacturing problem | 10/16 | |
| Valsartan and Diuretics | 3 | 26 Oct 2026 | Increased demand | 7/16 | |
| Venlafaxine | 3 | 21 Sep 2026 | Increased demand | 10/16 | |
| Acebutolol | 2 | 10 Mar 2026 | Manufacturing problem | 2/16 | |
| Acetylsalicylic Acid, Combinations with Psycholeptics | 2 | 4 Sep 2024 | Manufacturing problem | 1/16 | |
| Betamethasone | 2 | 28 Aug 2024 | Manufacturing problem | 4/16 | |
| Betamethasone | 2 | 8 Oct 2025 | Manufacturing problem | 5/16 | |
| Calcitriol | 2 | 4 Dec 2025 | Not stated | 6/16 | |
| Carmustine | 2 | 5 Jan 2026 | Manufacturing problem | 3/16 | |
| Cefotaxime | 2 | 1 Oct 2026 | Commercial decision or withdrawal | 7/16 | |
| Ciclosporin | 2 | 28 Sep 2026 | Manufacturing problem | 6/16 | |
| Citalopram | 2 | 24 Sep 2026 | Manufacturing problem | 5/16 | |
| Cough Suppressants and Expectorants | 2 | 20 Mar 2026 | Manufacturing problem | 1/16 | |
| Desloratadine | 2 | 12 Oct 2026 | Manufacturing problem | 7/16 | |
| Diclofenac | 2 | 27 Jun 2025 | Manufacturing problem | 3/16 | |
| Digitoxin | 2 | 1 Jul 2026 | Other | 1/16 | |
| Doxycycline | 2 | 30 Jul 2026 | Not stated | 1/16 | |
| Duloxetine | 2 | 24 Jun 2026 | Manufacturing problem | 12/16 | |
| Eltrombopag | 2 | 14 Apr 2026 | Manufacturing problem | 4/16 | |
| Etoricoxib | 2 | 10 Dec 2025 | Manufacturing problem | 7/16 | |
| Febuxostat | 2 | 16 Mar 2026 | Manufacturing problem | 6/16 | |
| Fluorouracil | 2 | 20 Dec 2024 | Not stated | 7/16 | |
| Fluoxetine | 2 | 30 Jul 2026 | Increased demand | 8/16 | |
| Furosemide and Potassium-Sparing Agents | 2 | 8 Apr 2026 | Manufacturing problem | 1/16 | |
| Haloperidol | 2 | 29 Oct 2026 | Manufacturing problem | 4/16 | |
| Hydrochlorothiazide | 2 | 19 Nov 2025 | Not stated | 3/16 | |
| Hydroxyzine | 2 | 26 Mar 2014 | Manufacturing problem | 2/16 | |
| Ibuprofen | 2 | 20 Jul 2026 | Manufacturing problem | 8/16 | |
| Icatibant | 2 | 12 Oct 2026 | Manufacturing problem | 8/16 | |
| Indometacin | 2 | 18 Feb 2026 | Manufacturing problem | 4/16 | |
| Ivabradine | 2 | 1 Apr 2026 | Manufacturing problem | 9/16 | |
| Latanoprost | 2 | 8 May 2024 | Manufacturing problem | 4/16 | |
| Letrozole | 2 | 26 Oct 2026 | Increased demand | 6/16 | |
| Levocetirizine | 2 | 5 Jul 2026 | Manufacturing problem | 4/16 | |
| Linezolid | 2 | 18 May 2026 | Manufacturing problem | 7/16 | |
| Lovastatin | 2 | 1 Sep 2018 | Manufacturing problem | 1/16 | |
| Mycophenolic Acid | 2 | 10 Jun 2026 | Manufacturing problem | 6/16 | |
| Nebivolol and Thiazides | 2 | 3 Aug 2026 | Manufacturing problem | 1/16 | |
| Olopatadine | 2 | 1 Sep 2018 | Manufacturing problem | 2/16 | |
| Oxycodone | 2 | 7 Sep 2026 | Increased demand | 6/16 | |
| Paclitaxel | 2 | 1 Oct 2026 | Increased demand | 7/16 | |
| Paricalcitol | 2 | 14 Sep 2026 | Regulatory or licensing | 1/16 | |
| Paroxetine | 2 | 4 Feb 2026 | Manufacturing problem | 8/16 | |
| Progesterone | 2 | 16 Jun 2023 | Manufacturing problem | 5/16 | |
| Propofol | 2 | 8 Apr 2020 | Manufacturing problem | 6/16 | |
| Propranolol | 2 | 9 Jul 2026 | Manufacturing problem | 7/16 | |
| Remifentanil | 2 | 22 Jan 2020 | Manufacturing problem | 5/16 | |
| Ropinirole | 2 | 4 Mar 2026 | Not stated | 8/16 | |
| Tamsulosin and Solifenacin | 2 | 14 Sep 2026 | Increased demand | 5/16 | |
| Telmisartan | 2 | 8 Jun 2026 | Distribution or logistics | 6/16 | |
| Teriflunomide | 2 | 8 Oct 2025 | Manufacturing problem | 4/16 | |
| Timolol, Combinations | 2 | 27 Aug 2021 | Manufacturing problem | 9/16 | |
| Tramadol | 2 | 30 Sep 2026 | Manufacturing problem | 7/16 | |
| Valsartan | 2 | 28 Sep 2026 | Manufacturing problem | 7/16 | |
| Valsartan, amlodipine and hydrochlorothiazide | 2 | 7 Sep 2026 | Manufacturing problem | 2/16 | |
| Verapamil | 2 | 7 Sep 2026 | Manufacturing problem | 5/16 | |
| Voriconazole | 2 | 15 Aug 2026 | Increased demand | 6/16 | |
| Zolpidem | 2 | 4 Sep 2026 | Manufacturing problem | 6/16 | |
| Aciclovir | 1 | 8 Jun 2026 | Manufacturing problem | 6/16 | |
| Acitretin | 1 | 1 Nov 2026 | Manufacturing problem | 2/16 | |
| Adalimumab | 1 | 13 Nov 2025 | Not stated | 8/16 | |
| Ambroxol | 1 | 27 Oct 2026 | Distribution or logistics | 3/16 | |
| Amikacin | 1 | 23 Nov 2026 | Increased demand | 4/16 | |
| Amiodarone | 1 | 26 Jun 2026 | Manufacturing problem | 5/16 | |
| Ampicillin | 1 | 11 Feb 2026 | Manufacturing problem | 2/16 | |
| Arsenic Trioxide | 1 | 13 May 2020 | Other | 2/16 | |
| Atazanavir | 1 | 22 May 2025 | Not stated | 2/16 | |
| Atomoxetine | 1 | 19 Aug 2026 | Commercial decision or withdrawal | 11/16 | |
| Atorvastatin and Ezetimibe | 1 | 27 Oct 2026 | Manufacturing problem | 6/16 | |
| Azacitidine | 1 | 22 Dec 2020 | Other | 6/16 | |
| Bilastine | 1 | 3 Jul 2026 | Manufacturing problem | 3/16 | |
| Bisacodyl | 1 | 5 Oct 2026 | Distribution or logistics | 2/16 | |
| Bortezomib | 1 | 20 Jan 2025 | Manufacturing problem | 5/16 | |
| Bosutinib | 1 | 20 Jul 2026 | Distribution or logistics | 2/16 | |
| Budesonide | 1 | 11 Nov 2024 | Manufacturing problem | 5/16 | |
| Cabergoline | 1 | 1 Jan 2015 | Manufacturing problem | 4/16 | |
| Cabergoline | 1 | 23 Aug 2026 | Not stated | 3/16 | |
| Captopril | 1 | 2 Jul 2025 | Manufacturing problem | 1/16 | |
| Cetirizine | 1 | 15 Dec 2026 | Manufacturing problem | 4/16 | |
| Cetrorelix | 1 | 13 Nov 2025 | Not stated | 3/16 | |
| Chloroquine | 1 | 21 Nov 2019 | Active ingredient shortage | 1/16 | |
| Clindamycin | 1 | 8 Oct 2025 | Other | 9/16 | |
| Clobetasol | 1 | 15 Aug 2026 | Not stated | 2/16 | |
| Clonidine | 1 | 2 Aug 2023 | Manufacturing problem | 2/16 | |
| Clotrimazole | 1 | 4 Sep 2026 | Manufacturing problem | 3/16 | |
| Clozapine | 1 | 8 Jul 2024 | Regulatory or licensing | 3/16 | |
| Colecalciferol | 1 | 21 Sep 2026 | Manufacturing problem | 8/16 | |
| Dequalinium | 1 | 24 Aug 2026 | Distribution or logistics | 1/16 | |
| Dexamethasone | 1 | 5 Oct 2026 | Manufacturing problem | 10/16 | |
| Diclofenac | 1 | 16 Oct 2026 | Manufacturing problem | 10/16 | |
| Disulfiram | 1 | 15 May 2026 | Not stated | 1/16 | |
| Doxazosin | 1 | 28 Sep 2026 | Manufacturing problem | 5/16 | |
| Doxycycline | 1 | 15 Dec 2025 | Manufacturing problem | 7/16 | |
| Dutasteride | 1 | 1 Apr 2026 | Increased demand | 4/16 | |
| Ebastine | 1 | 27 Aug 2026 | Manufacturing problem | 4/16 | |
| Efavirenz | 1 | 14 May 2025 | Manufacturing problem | 3/16 | |
| Emtricitabine, Tenofovir Disoproxil and Efavirenz | 1 | 20 Jan 2025 | Manufacturing problem | 4/16 | |
| Entecavir | 1 | 2 Jun 2026 | Not stated | 8/16 | |
| Etidronic Acid and Calcium, Sequential | 1 | 1 May 2018 | Manufacturing problem | 1/16 | |
| Everolimus | 1 | 10 Jan 2024 | Manufacturing problem | 1/16 | |
| Exemestane | 1 | 7 Nov 2024 | Distribution or logistics | 3/16 | |
| Filgrastim | 1 | 1 Sep 2026 | Manufacturing problem | 4/16 | |
| Finasteride | 1 | 16 Oct 2026 | Distribution or logistics | 8/16 | |
| Flecainide | 1 | 12 Aug 2026 | Manufacturing problem | 5/16 | |
| Fludarabine | 1 | 20 Oct 2026 | Not stated | 3/16 | |
| Fulvestrant | 1 | 31 Aug 2026 | Manufacturing problem | 5/16 | |
| Furosemide | 1 | 12 Oct 2026 | Distribution or logistics | 11/16 | |
| Gemcitabine | 1 | 15 May 2025 | Not stated | 9/16 | |
| Gliclazide | 1 | 14 Sep 2026 | Manufacturing problem | 8/16 | |
| Hydrochlorothiazide and Potassium-Sparing Agents | 1 | 13 Jul 2026 | Manufacturing problem | 1/16 | |
| Hydroxocobalamin | 1 | 4 Nov 2024 | Other | 3/16 | |
| Hydroxychloroquine | 1 | 5 Jan 2026 | Not stated | 3/16 | |
| Ibandronic Acid | 1 | 6 Dec 2023 | Manufacturing problem | 4/16 | |
| Ibuprofen | 1 | 2 Oct 2026 | Manufacturing problem | 1/16 | |
| Indapamide | 1 | 20 Jul 2026 | Manufacturing problem | 4/16 | |
| Irbesartan | 1 | 15 Nov 2026 | Not stated | 6/16 | |
| Irbesartan and Diuretics | 1 | 10 Mar 2024 | Manufacturing problem | 4/16 | |
| Isosorbide Mononitrate | 1 | 15 Jun 2026 | Manufacturing problem | 5/16 | |
| Itraconazole | 1 | 12 Oct 2026 | Manufacturing problem | 11/16 | |
| Ivermectin | 1 | 29 Oct 2026 | Not stated | 2/16 | |
| Ketotifen | 1 | 29 Oct 2026 | Manufacturing problem | 2/16 | |
| Lacidipine | 1 | 14 Sep 2026 | Manufacturing problem | 1/16 | |
| Lacosamide | 1 | 15 Oct 2026 | Not stated | 6/16 | |
| Lactic Acid Producing Organisms | 1 | 11 Feb 2026 | Manufacturing problem | 1/16 | |
| Lamivudine | 1 | 26 Oct 2026 | Increased demand | 3/16 | |
| Lamivudine and Abacavir | 1 | 29 Jan 2025 | Manufacturing problem | 2/16 | |
| Lamotrigine | 1 | 13 Oct 2026 | Manufacturing problem | 9/16 | |
| Lansoprazole | 1 | 16 Jun 2023 | Not stated | 8/16 | |
| Lenalidomide | 1 | 16 Sep 2026 | Not stated | 10/16 | |
| Levodropropizine | 1 | 13 Oct 2026 | Manufacturing problem | 1/16 | |
| Levonorgestrel and Ethinylestradiol | 1 | 11 Feb 2026 | Manufacturing problem | 3/16 | |
| Levonorgestrel and Ethinylestradiol | 1 | 11 Feb 2026 | Manufacturing problem | 1/16 | |
| Levothyroxine Sodium | 1 | 21 Oct 2026 | Not stated | 6/16 | |
| Liraglutide | 1 | 14 May 2026 | Not stated | 4/16 | |
| Loperamide | 1 | 19 Oct 2026 | Manufacturing problem | 6/16 | |
| Melphalan | 1 | 5 Jun 2026 | Manufacturing problem | 4/16 | |
| Methylprednisolone | 1 | 29 Feb 2016 | Manufacturing problem | 8/16 | |
| Metoclopramide | 1 | 22 Oct 2026 | Manufacturing problem | 6/16 | |
| Mitomycin | 1 | 1 May 2020 | Increased demand | 7/16 | |
| Mometasone | 1 | 12 Feb 2025 | Manufacturing problem | 5/16 | |
| Nevirapine | 1 | 1 Jul 2027 | Not stated | 4/16 | |
| Nitrendipine | 1 | 30 Jul 2025 | Manufacturing problem | 3/16 | |
| Norfloxacin | 1 | 22 Dec 2015 | Manufacturing problem | 3/16 | |
| Nystatin | 1 | 3 Jun 2026 | Manufacturing problem | 1/16 | |
| Olmesartan Medoxomil and Amlodipine | 1 | 3 Aug 2026 | Manufacturing problem | 4/16 | |
| Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | 1 | 25 Oct 2026 | Not stated | 3/16 | |
| Oseltamivir | 1 | 22 Jun 2026 | Not stated | 4/16 | |
| Oxaliplatin | 1 | 15 Jul 2026 | Manufacturing problem | 10/16 | |
| Oxycodone and Paracetamol | 1 | 18 Jun 2025 | Manufacturing problem | 2/16 | |
| Palonosetron | 1 | 14 Nov 2025 | Not stated | 5/16 | |
| Pentoxifylline | 1 | 13 Feb 2026 | Manufacturing problem | 5/16 | |
| Phenoxymethylpenicillin | 1 | 17 Nov 2026 | Manufacturing problem | 5/16 | |
| Piperacillin and Beta-Lactamase Inhibitor | 1 | 31 Jul 2026 | Commercial decision or withdrawal | 8/16 | |
| Plerixafor | 1 | 1 Feb 2026 | Not stated | 7/16 | |
| Prazosin | 1 | 10 Jun 2026 | Manufacturing problem | 3/16 | |
| Propafenone | 1 | 14 Jan 2025 | Not stated | 3/16 | |
| Rasagiline | 1 | 12 Oct 2026 | Manufacturing problem | 2/16 | |
| Rilmenidine | 1 | 24 Aug 2026 | Manufacturing problem | 1/16 | |
| Rivastigmine | 1 | 25 Sep 2026 | Not stated | 6/16 | |
| Rosuvastatin and Acetylsalicylic Acid | 1 | 1 Oct 2026 | Not stated | 1/16 | |
| Salbutamol | 1 | 15 Aug 2026 | Not stated | 6/16 | |
| Salmeterol and Fluticasone | 1 | 8 Jun 2026 | Manufacturing problem | 6/16 | |
| Selegiline | 1 | 20 Jan 2020 | Manufacturing problem | 1/16 | |
| Solifenacin | 1 | 29 Sep 2026 | Manufacturing problem | 6/16 | |
| Sugammadex | 1 | 31 Aug 2026 | Active ingredient shortage | 6/16 | |
| Terbinafine | 1 | 18 Oct 2016 | Manufacturing problem | 5/16 | |
| Teriparatide | 1 | 10 Aug 2026 | Not stated | 5/16 | |
| Tetracycline | 1 | 25 Apr 2025 | Active ingredient shortage | 2/16 | |
| Tolvaptan | 1 | 26 Oct 2026 | Not stated | 2/16 | |
| Travoprost | 1 | 12 May 2026 | Manufacturing problem | 7/16 | |
| Tryptophan | 1 | 7 Aug 2024 | Manufacturing problem | 1/16 | |
| Valaciclovir | 1 | 5 Oct 2026 | Manufacturing problem | 10/16 | |
| Valganciclovir | 1 | 22 Sep 2026 | Not stated | 5/16 | |
| Zolmitriptan | 1 | 18 Mar 2022 | Manufacturing problem | 4/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.